Serruys, Patrick W; Onuma, Yoshinobu; Ormiston, John A; de Bruyne, Bernard; Regar, Evelyn; Dudek, Dariusz; Thuesen, Leif; Smits, Pieter C; Chevalier, Bernard; McClean, Dougal; Koolen, Jacques; Windecker, Stephan; Whitbourn, Robert; Meredith, Ian; Dorange, Cécile; Veldhof, Susan; Miquel-Hebert, Karine; Rapoza, Richard; García-García, Hector M (2010). Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes. Circulation, 122(22), pp. 2301-12. Baltimore, Md.: Lippincott Williams & Wilkins 10.1161/CIRCULATIONAHA.110.970772
Full text not available from this repository. (Request a copy)The first generation of the bioresorbable everolimus drug-eluting vascular scaffold showed signs of shrinkage at 6 months, which largely contributed to late luminal loss. Nevertheless, late luminal loss was less than that observed with bare metal stents. To maintain the mechanical integrity of the device up to 6 months, the scaffold design and manufacturing process of its polymer were modified.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
UniBE Contributor: |
Windecker, Stephan |
ISSN: |
0009-7322 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:10 |
Last Modified: |
05 Dec 2022 14:01 |
Publisher DOI: |
10.1161/CIRCULATIONAHA.110.970772 |
PubMed ID: |
21098436 |
Web of Science ID: |
000284691700018 |
URI: |
https://boris.unibe.ch/id/eprint/1627 (FactScience: 203405) |
Actions (login required)
 |
Edit item |